Optical Biosensor to Screen Blood Donors for Pathogens

An integrated optical biosensor is being developed to screen blood donors for human immunodeficiency virus (HIV)/AIDS, hepatitis, and tuberculosis in a single test at the point of collection (POC).

Biomagnetics Diagnostics Corp. (Orangevale, CA, USA), developer of diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, has acquired additional intellectual property rights from Los Alamos National Security (Los Alamos, MN, USA). On November 30, 2009, Biomagnetics Diagnostics Corp announced that it finalized an agreement that gives it access to the triggered optical biosensor and Integrated Optical Biosensor System (IBOS) technology developed at Los Alamos National Laboratory.

The technology is capable of simultaneously detecting multiple pathogens from a single blood sample. Biomagnetics Diagnostics plans to integrate these technologies into a handheld blood diagnostic device that can be utilized by relatively unskilled personnel to screen potential blood donors for various pathogens at the point of collection (POC).

Related Links:
Biomagnetics Diagnostics Corp.
Los Alamos National Security